CIK 0001104506
- Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- EIN
- 541972729
- Phone
- +1 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,785,602
- in 2 filings, $14.7M under 10b5-1 plans
Net −$17,785,602. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-15 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Sale | −1,830 | $19.22 | $35K | 96,714 |
| 2023-05-15 | Lewis William Chair and CEO | Sale | −6,048 | $19.23 | $116K | 352,158 |
| 2023-05-15 | Flammer Martina M.D. Chief Medical Officer | Sale | −2,576 | $19.28 | $50K | 116,624 |
| 2023-05-15 | Bonstein Sara Chief Financial Officer | Sale | −2,210 | $19.30 | $43K | 119,229 |
| 2023-05-15 | Adsett Roger Chief Operating Officer | Sale | −2,847 | $19.27 | $55K | 164,302 |
| 2023-05-15 | SHAROKY MELVIN MD Director | Purchase | +10,000 | $19.29 | $193K | 298,615 |
| 2023-05-15 | SHAROKY MELVIN MD Director | Purchase | +10,000 | $19.29 | $193K | 10,000 |
| 2023-05-12 | Lewis William Chair and CEO | Exercise or conversion | +67,257 | $12.44 | $837K | 67,257 |
| 2023-05-12 | Lewis William Chair and CEO | Exercise or conversion | +83,333 | $12.44 | $1.0M | 150,590 |
| 2023-05-12 | Lewis William Chair and CEO | Exercise or conversion | +83,334 | $12.44 | $1.0M | 233,924 |
| 2023-05-12 | Lewis William Chair and CEO | Exercise or conversion · Stock Option (right to buy) | +67,257 | $12.44 | $837K | 0 |
| 2023-05-12 | Lewis William Chair and CEO | Exercise or conversion · Stock Option (right to buy) | +83,334 | $12.44 | $1.0M | 0 |
| 2023-05-12 | Lewis William Chair and CEO | Exercise or conversion · Stock Option | +83,333 | $12.44 | $1.0M | 0 |
| 2023-05-11 | SHAROKY MELVIN MD Director | Grant or award | +13,192 | 290,415 | ||
| 2023-05-11 | SHAROKY MELVIN MD Director | Gift | −1,800 | 288,615 | ||
| 2023-05-11 | SCHAFER CAROL Director | Grant or award | +13,192 | 45,097 | ||
| 2023-05-11 | MCGIRR DAVID W J Director | Grant or award | +13,192 | 85,753 | ||
| 2023-05-11 | LEE LEO Director | Grant or award | +13,192 | 111,457 | ||
| 2023-05-11 | Desjardins Clarissa Director | Grant or award | +13,192 | 48,787 | ||
| 2023-05-11 | Brennan David R Director | Grant or award | +13,192 | 108,713 |
Page 47 of 54 · 1,061 trades